Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
B.R.A.I.N. Biotechnology Research and Information Network AG (GB:0RFI)
LSE:0RFI
Holding GB:0RFI?
Track your performance easily
0RFI Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.47 - €4.47
Previous CloseN/A
Volume57.99K
Average Volume (3M)4.58K
Market Cap
€71.22M
Enterprise Value€50.18M
Total Cash (Recent Filing)$18.46M
Total Debt (Recent Filing)$6.24M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding21,847,494
10 Day Avg. Volume96
30 Day Avg. Volume4,580
Standard Deviation0.18
R-Squared0.13
Alpha-0.00180
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.52
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.70
Enterprise Value/Revenue0.95
Enterprise Value/Gross Profit1.83
Enterprise Value/Ebitda-31.62
Forecast
1Y Price Target
€6.45Price Target Upside96.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
0RFI FAQ
What was B.R.A.I.N. Biotechnology Research and Information Network AG’s price range in the past 12 months?
B.R.A.I.N. Biotechnology Research and Information Network AG lowest share price was €1.47 and its highest was €4.47 in the past 12 months.
What is B.R.A.I.N. Biotechnology Research and Information Network AG’s market cap?
B.R.A.I.N. Biotechnology Research and Information Network AG’s market cap is €71.22M.
When is B.R.A.I.N. Biotechnology Research and Information Network AG’s upcoming earnings report date?
B.R.A.I.N. Biotechnology Research and Information Network AG’s upcoming earnings report date is Feb 26, 2025 which is in 27 days.
How were B.R.A.I.N. Biotechnology Research and Information Network AG’s earnings last quarter?
B.R.A.I.N. Biotechnology Research and Information Network AG released its earnings results on Jan 15, 2025. The company reported -€0.3 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.3.
Is B.R.A.I.N. Biotechnology Research and Information Network AG overvalued?
According to Wall Street analysts B.R.A.I.N. Biotechnology Research and Information Network AG’s price is currently Undervalued.
Does B.R.A.I.N. Biotechnology Research and Information Network AG pay dividends?
B.R.A.I.N. Biotechnology Research and Information Network AG does not currently pay dividends.
What is B.R.A.I.N. Biotechnology Research and Information Network AG’s EPS estimate?
B.R.A.I.N. Biotechnology Research and Information Network AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does B.R.A.I.N. Biotechnology Research and Information Network AG have?
B.R.A.I.N. Biotechnology Research and Information Network AG has 21,847,494 shares outstanding.
What happened to B.R.A.I.N. Biotechnology Research and Information Network AG’s price movement after its last earnings report?
B.R.A.I.N. Biotechnology Research and Information Network AG reported an EPS of -€0.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.279%.
Which hedge fund is a major shareholder of B.R.A.I.N. Biotechnology Research and Information Network AG?
Currently, no hedge funds are holding shares in GB:0RFI
---
B.R.A.I.N. Biotechnology Research and Information Network Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€6.45 (96.65% Upside)
€6.45 (96.65% Upside)
Insider Transactions
Bought Shares
Worth €35.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.17%
12-Months-Change
Fundamentals
Return on Equity
-64.72%
Trailing 12-Months
Asset Growth
25.09%
Trailing 12-Months
Company Description
B.R.A.I.N. Biotechnology Research and Information Network AG
Brain Biotechnology Research and Information Network AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. Its operating segments is BioScience segment and BioIndustrial segment. Generating a majority of its revenue from the BioIndustrial segment.
---
0RFI Stock 12 Month Forecast
Average Price Target
€6.45
▲(96.65% Upside)
Technical Analysis
Best Analysts Covering 0RFI
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+43.37%
reiterated a buy rating 16 days ago
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +43.37% per trade.
---